Показать сокращенную информацию
dc.contributor.author | Gusakov E.A. | |
dc.contributor.author | Topchu I.A. | |
dc.contributor.author | Mazitova A.M. | |
dc.contributor.author | Dorogan I.V. | |
dc.contributor.author | Bulatov E.R. | |
dc.contributor.author | Serebriiskii I.G. | |
dc.contributor.author | Abramova Z.I. | |
dc.contributor.author | Tupaeva I.O. | |
dc.contributor.author | Demidov O.P. | |
dc.contributor.author | Toan D.N. | |
dc.contributor.author | Lam T.D. | |
dc.contributor.author | Bang D.N. | |
dc.contributor.author | Boumber Y.A. | |
dc.contributor.author | Sayapin Y.A. | |
dc.contributor.author | Minkin V.I. | |
dc.date.accessioned | 2022-02-09T20:43:59Z | |
dc.date.available | 2022-02-09T20:43:59Z | |
dc.date.issued | 2021 | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/169894 | |
dc.description.abstract | Tropolones are promising organic compounds that can have important biologic effects. We developed a series of new 2-quinolyl-1,3-tropolones derivatives that were prepared by the acid-catalyzed reaction of 4,7-dichloro-2-methylquinolines with 1,2-benzoquinones. 2-Quinolyl-1,3-tropolones have been synthesized and tested for their anti-proliferative activity against several human cancer cell lines. Two compounds (3d and mixture B of 3i-k) showed excellent activity against six cancer cell lines of different tissue of origin. The promising compounds 3d and mixture B of 3i-k also demonstrated induction of apoptotic cell death of ovarian cancer (OVCAR-3, OVCAR-8) and colon cancer (HCT 116) cell lines and affected ERK signaling. In summary, 2-quinolyl-1,3-tropolones are promising compounds for development of effective anticancer agents. This journal is | |
dc.title | Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 8 | |
dc.relation.ispartofseries-volume | 11 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 4555 | |
dc.source.id | SCOPUS-2021-11-8-SID85100133501 |